TELA Bio (TELA) Revenue & Revenue Breakdown
TELA Bio Revenue Highlights
Latest Revenue (Y)
$58.45M
Latest Revenue (Q)
$16.09M
Main Geography (Y)
Non-US
TELA Bio Revenue by Period
TELA Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $58.45M | 41.13% |
| 2022-12-31 | $41.42M | 40.58% |
| 2021-12-31 | $29.46M | 61.77% |
| 2020-12-31 | $18.21M | 17.91% |
| 2019-12-31 | $15.45M | 86.68% |
| 2018-12-31 | $8.27M | 94.91% |
| 2017-12-31 | $4.25M | - |
TELA Bio generated $58.45M in revenue during NA 2023, up 41.13% compared to the previous quarter, and up 706.47% compared to the same period a year ago.
TELA Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $16.09M | -3.08% |
| 2024-03-31 | $16.60M | -2.32% |
| 2023-12-31 | $17.00M | 12.93% |
| 2023-09-30 | $15.05M | 3.85% |
| 2023-06-30 | $14.49M | 21.71% |
| 2023-03-31 | $11.91M | 2.47% |
| 2022-12-31 | $11.62M | 4.15% |
| 2022-09-30 | $11.16M | 7.24% |
| 2022-06-30 | $10.41M | 26.42% |
| 2022-03-31 | $8.23M | -1.71% |
| 2021-12-31 | $8.37M | 9.41% |
| 2021-09-30 | $7.65M | 1.27% |
| 2021-06-30 | $7.56M | 28.60% |
| 2021-03-31 | $5.88M | 3.71% |
| 2020-12-31 | $5.67M | 6.66% |
| 2020-09-30 | $5.31M | 51.50% |
| 2020-06-30 | $3.51M | -5.88% |
| 2020-03-31 | $3.73M | -23.40% |
| 2019-12-31 | $4.86M | 22.43% |
| 2019-09-30 | $3.97M | 20.28% |
| 2019-06-30 | $3.30M | -0.09% |
| 2019-03-31 | $3.31M | 36.22% |
| 2018-12-31 | $2.43M | 9.72% |
| 2018-09-30 | $2.21M | 21.71% |
| 2018-06-30 | $1.82M | - |
| 2018-03-31 | $1.82M | - |
TELA Bio generated $16.09M in revenue during Q2 2024, up -3.08% compared to the previous quarter, and up 135.12% compared to the same period a year ago.
TELA Bio Revenue Breakdown
TELA Bio Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 19 |
|---|---|---|---|
| Non-US | $6.10M | $3.20M | - |
| Europe | - | - | $500.00K |
TELA Bio's latest annual revenue breakdown by geography, as of Dec 23: Non-US (100.00%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 |
|---|---|---|---|---|---|
| Non-US | $2.40M | $2.30M | $3.60M | $1.50M | $1.00M |
TELA Bio's latest quarterly revenue breakdown by geography, as of Jun 24: Non-US (100.00%).
TELA Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VREX | Varex Imaging | $893.40M | $209.10M |
| TCMD | Tactile Systems | $274.42M | $317.00K |
| TMDX | TransMedics Group | $241.62M | $114.31M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| AXGN | AxoGen | $159.01M | $47.91M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $39.97M |
| RXST | RxSight | $89.08M | $45.52M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| TELA | TELA Bio | $58.45M | $16.09M |
| CVRX | CVRx | $39.30M | $11.81M |
| TBIO | Telesis Bio | $27.51M | $3.44M |
| CLPT | ClearPoint Neuro | $23.95M | $7.86M |
| DCTH | Delcath Systems | $2.06M | $7.77M |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
TELA Revenue FAQ
What is TELA Bio’s yearly revenue?
TELA Bio's yearly revenue for 2023 was $58.45M, representing an increase of 41.13% compared to 2022. The company's yearly revenue for 2022 was $41.42M, representing an increase of 40.58% compared to 2021. TELA's yearly revenue for 2021 was $29.46M, representing an increase of 61.77% compared to 2020.
What is TELA Bio’s quarterly revenue?
TELA Bio's quarterly revenue for Q2 2024 was $16.09M, a -3.08% decrease from the previous quarter (Q1 2024), and a 11.02% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $16.6M, a -2.32% decrease from the previous quarter (Q4 2023), and a 39.42% increase year-over-year (Q1 2023). TELA's quarterly revenue for Q4 2023 was $17M, a 12.93% increase from the previous quarter (Q3 2023), and a 46.26% increase year-over-year (Q4 2022).
What is TELA Bio’s revenue growth rate?
TELA Bio's revenue growth rate for the last 3 years (2021-2023) was 98.39%, and for the last 5 years (2019-2023) was 278.43%.